Skip to main content

Table 1 Baseline characteristics of the subjects

From: Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease

  Placebo (n = 19) LC (n = 20)
  Mean s.d. Mean s.d
Gender (male) 19 20
Age (y) 72.7 10.1 71.9 10.6
SBP (mmHg) 127.3 6.0 128.4 10.4
DBP (mmHg) 74.5 4.4 72.3 4.7
General obesitya (%) 36.8 30.0
Central obesitya (%) 84.2 65
Smokingb (n, %) 3 (15.8 %) 4 (20.0 %)
Drinkingc (n, %) 3 (15.8 %) 3 (15.0 %)
Dietary intake     
Energy (kcal/day) 1501.4 63.7 1534.2 41.6
Protein (g/day, % of total calories) 54.2 (14.2) 11.2 51.1 (12.9) 6.9
Fat (g/day, % of total calories) 43.3 (26.4) 9.7 43.2 (23.8) 10.6
 SFA (g/day) 11.7 5.3 10.6 5.4
 PUFA (g/day) 14.0 3.5 15.9 3.6
 MUFA (g/day) 13.3 3.8 13.0 4.9
Carbohydrate (g/day, % of total calories) 225.3 (60.3) 16.3 236.7 (63.5) 24.7
  1. aGeneral obesity was defined as body mass index ≥ 27 kg/m2 and central obesity was defined as waist circumferences ≥ 90 cm. bSmoking: the individual currently smokes one or more cigarettes per day. cDrinking: the individual regularly drinks one or more drinks per day
  2. DBP diastolic blood pressure; LC L-carnitine; MUFA monounsaturated fatty acids; PUFA polyunsaturated fatty acids; SBP systolic blood pressure; SFA saturated fatty acids